Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TLV/KMDA stock hub

TLV/KMDA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/KMDAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Tel Aviv Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TLV/KMDA

In the news

Latest news · TLV/KMDA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16

P25 n/aP50 n/aP75 n/a

Trailing P/E22.4

P25 n/aP50 n/aP75 n/a

ROE7.6

P25 n/aP50 n/aP75 n/a

ROIC11

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/KMDA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	462
Employees Change	42%
Employees Change Percent	10
Enterprise value	ILA 1.2B
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	IL0010941198
Last refreshed	2026-05-10
Market cap	ILA 1.4B
Price	ILA 2,494
Price currency	ILA
Rev Per Employee	1,245,252.12x
Sector	Healthcare
Sic	2836
Symbol	tlv/KMDA
Website	https://www.kamada.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.48%
EV Earnings	19.18x
EV/EBIT	14.77x
EV/EBITDA	9.41x
EV/FCF	24.76x
EV/Sales	2.15x
FCF yield	3.47%
Forward P/E	15.95x
P/B ratio	1.68x
P/E ratio	22.35x
P/S ratio	2.5x
PE Ratio10 Y	23.06x
PE Ratio3 Y	30.67x
PE Ratio5 Y	30.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.54%
EBITDA Margin	21.9%
FCF margin	8.67%
Gross margin	42.34%
Gross Profit	ILA 243.6M
Gross Profit Growth	9.2%
Gross Profit Growth Q	-0.38%
Gross Profit Growth3 Y	17.83%
Gross Profit Growth5 Y	9.95%
Net Income	ILA 64.4M
Net Income Growth	39.66%
Net Income Growth Q	-6.46%
Net Income Growth Years	3%
Net Income Growth5 Y	3.34%
Pretax Margin	13%
Profit Margin	11.19%
Profit Per Employee	ILA 139,375
Profitable Years	3
ROA	4.37
Roa5y	2.16
ROCE	7.92
ROE	7.64
Roe5y	2.95
ROIC	11.02
Roic5y	6.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.42%
Cagr15y	-0.92%
Cagr1y	3.91%
Cagr20y	3.65%
Cagr3y	13.76%
Cagr5y	5.7%
EPS Growth	40
EPS Growth Q	-14.11
EPS Growth Years	3
EPS Growth5 Y	-1.63
FCF Growth	-57.55%
FCF Growth Q	-35.9%
FCF Growth3 Y	-14.24%
FCF Growth5 Y	2.81%
OCF Growth	-46.44%
OCF Growth Q	-27.24%
OCF Growth3 Y	-3.75%
OCF Growth5 Y	5.94%
Revenue Growth	12.12x
Revenue Growth Q	14.54x
Revenue Growth Quarters	8x
Revenue Growth Years	4x
Revenue Growth3 Y	11.74x
Revenue Growth5 Y	6.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.48
Assets	ILA 1.2B
Cash	ILA 240.6M
Current Assets	ILA 560.1M
Current Liabilities	ILA 137.5M
Debt	ILA 36.9M
Debt EBITDA	ILA 0.28
Debt Equity	ILA 0.04
Debt FCF	ILA 0.74
Equity	ILA 857.8M
Interest Coverage	30.36
Liabilities	ILA 349.5M
Long Term Assets	ILA 647.2M
Long Term Liabilities	ILA 212M
Net Cash	ILA 203.7M
Net Cash By Market Cap	ILA 14.16
Net Cash Growth	-5.14%
Net Debt EBITDA	ILA -1.62
Net Debt Equity	ILA -0.24
Net Debt FCF	ILA -4.09
Tangible Book Value	ILA 454.8M
Tangible Book Value Per Share	ILA 7.88
WACC	5.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.07
Inventory Turnover	1.27
Net Working Capital	ILA 230.6M
Quick ratio	2.2
Working Capital	ILA 464.4M
Working Capital Turnover	ILA 4.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.91%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	ILA 0.72
Dividend Years	2
Dividend Yield	2.91%
Ex Div Date	2026-03-23
Last Dividend	ILA 0.77
Payout Frequency	Annual
Payout Ratio	57.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	69.56%
1Y total return	3.91%
200-day SMA	2,448.7
3Y total return	47.24%
50-day SMA	2,609.6
50-day SMA vs 200-day SMA	50over200
5Y total return	31.94%
All Time High	6,200
All Time High Change	-59.77%
All Time High Date	2014-03-03
All Time Low	455.5
All Time Low Change	447.53%
All Time Low Date	2008-12-29
ATR	74.37
Beta	0.2
Beta1y	0.24
Beta2y	0.25
Ch YTD	10.35
High	2,534
High52	2,890
High52 Date	2026-02-26
High52ch	-13.7%
Low	2,407
Low52	1,956
Low52 Date	2025-12-08
Low52ch	27.51%
Ma50ch	-4.43%
Price vs 200-day SMA	1.85%
RSI	48.82
RSI Monthly	55.21
RSI Weekly	42.76
Sharpe ratio	0.26x
Sortino ratio	0.61
Total Return	1.99%
Tr YTD	13.61
Tr15y	-12.93%
Tr1m	-4.15%
Tr1w	2.76%
Tr3m	1.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA 83.6M
Operating Income Growth	30.83
Operating Income Growth Q	-30.07
Operating Income Growth3 Y	79.55
Operating Income Growth5 Y	6.4
Operating margin	14.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,821,060%
Net Borrowing	-2,819,772
Shares Insiders	4.67%
Shares Institutions	20.32%
Shares Out	57,686,056
Shares Qo Q	0.89%
Shares Yo Y	0.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA 47.2M
Average Volume	47,012.9x
Bv Per Share	14.87
CAPEX	ILA -31.4M
Ch10y	60.18
Ch15y	-17.74
Ch1m	-4.15
Ch1w	2.76
Ch1y	0.93
Ch20y	89.66
Ch3m	-1.19
Ch3y	39.1
Ch5y	24.64
Ch6m	14.93
Change	1.3%
Change From Open	3.49
Close	2,462
Days Gap	-2.11
Depreciation Amortization	38,522,379
Dollar Volume	140,823,710
Earnings Date	2026-05-13
EBIT	ILA 83.6M
EBITDA	ILA 126M
EPS	ILA 1.12
F Score	6
FCF	ILA 49.9M
FCF EV Yield	4.04x
FCF Per Share	ILA 0.86
Financing CF	-58,483,860
Fiscal Year End	December
Founded	1,990
Goodwill	87,938,013
Graham Number	19.32147
Graham Upside	-99.23
Income Tax	ILA 10.4M
Investing CF	-31,363,544
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Lynch Fair Value	ILA 5.58
Lynch Upside	-99.78
Ma150	2,442.4
Ma150ch	2.11%
Ma20	2,478.5
Ma20ch	0.63%
Net CF	-9,455,608
Next Earnings Date	2026-05-13
Open	2,410
P FCF Ratio	28.85
P OCF Ratio	17.7
Payment Date	2026-04-07
Position In Range	68.5
Ppne	145,824,567
Price Date	2026-05-08
Price EBITDA	ILA 11.42
Ptbv Ratio	3.16
Relative Volume	1.2x
Revenue	575,306,480x
SBC By Revenue	0.47x
Share Based Comp	2,693,860
Tax By Revenue	1.81x
Tax Rate	13.93%
Tr20y	104.69%
Tr6m	18.32%
Volume	56,465
Z Score	3.33

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TLV/KMDA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.9%

$0.72 annual per share

Payout ratio

+57.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+2.0%

Next ex-dividend date: 2026-03-23

Performance

TLV/KMDA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/KMDA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.3%

Share of float held by funds and institutions

Insider ownership

+4.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.9%

Negative means the company is buying back shares.

Technical

TLV/KMDA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.8

Neutral momentum band

Price vs 200-day MA

+1.9%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/KMDA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/KMDA stock rating?

tlv/KMDA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/KMDA analysis?

The full report lives at /stocks/tlv/KMDA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/KMDA?

The latest report frames tlv/KMDA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/KMDA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.